Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Socías, M Eugenia ^a,b   Sued, Omar ^b   Laufer, Natalia ^a,b   Lázaro, María E ^c   Mingrone, Horacio ^d   Pryluka, Daniel ^e   Remondegui, Carlos ^f   Figueroa, María I ^a   Cesar, Carina ^b   Gun, Ana ^b   Turk, Gabriela ^g   Bouzas, María B ^d   Kavasery, Ravi ^h   Krolewiecki, Alejandro ^b   Pérez, Héctor ^a   Salomán, Horacio ^g   Cahn, Pedro ^a,b  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b Fundacián Huésped ^*  (Argentina)

^c Hospital Zonal Ramán Carrillo   (Argentina)

^d Hospital M iz   (Argentina)

^e MEDICUS   (Argentina)

^f Hospital Zonal General Agudos San Roque   (Argentina)

^g UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARGENTINA; ARTICLE; CD4+ T LYMPHOCYTE; CRYPTOCOCCAL MENINGITIS; CRYPTOSPORIDIOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE DURATION; DISEASE REGISTRY; ESOPHAGUS CANDIDIASIS; FEMALE; FOLLOW UP; HISTOPLASMOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROVIRUS INFECTION; SEROCONVERSION; VIRUS LOAD; VIRUS TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; METHODOLOGY; PATHOLOGY; TIME; TREATMENT OUTCOME; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ARGENTINA; DISEASE PROGRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 81155158293     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-40     Document Type: Article

References (60)

1. Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. Sydney Primary HIV Infection Study Group. Kaufmann GR, Cunningham P, Zaunders J, Law M, Vizzard J, Carr A, Cooper DA, J Acquir Immune Defic Syndr 1999 22 437 444 10961604 (Pubitemid 30027493)
2. Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials. Buchacz K, Hu DJ, Vanichseni S, Mock PA, Chaowanachan T, Srisuwanvilai LO, Gvetadze R, Van Griensven F, Tappero JW, Kitayaporn D, Kaewkungwal J, Choopanya K, Mastro TD, J Acquir Immune Defic Syndr 2004 36 853 860 10.1097/00126334-200407010-00013 15213570 (Pubitemid 38859352)
3. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. Hubert JB, Burgard M, Dussaix E, Tamalet C, Deveau C, Le Chenadec J, Chaix ML, Marchadier E, Vilde JL, Delfraissy JF, Meyer L, Rouzioux C, Aids 2000 14 123 131 10.1097/00002030-200001280-00007 10708282 (Pubitemid 30116437)
4. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW, J Infect Dis 2000 181 872 880 10.1086/315339 10720507 (Pubitemid 30194468)
5. Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort. Schiffer V, Deveau C, Meyer L, Iraqui I, Nguyen-Wartel A, Chaix ML, Delfraissy JF, Rouzioux C, Venet A, Goujard C, HIV Med 2004 5 326 333 10.1111/j.1468-1293.2004.00231.x 15369507 (Pubitemid 39276330)
6. The natural history of HIV-1 infection in young Thai men after seroconversion. Rangsin R, Chiu J, Khamboonruang C, Sirisopana N, Eiumtrakul S, Brown AE, Robb M, Beyrer C, Ruangyuttikarn C, Markowitz LE, Nelson KE, J Acquir Immune Defic Syndr 2004 36 622 629 10.1097/00126334-200405010-00011 15097306 (Pubitemid 38544512)
7. Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. Djomand G, Duerr A, Faulhaber JC, Struchiner CJ, Pacheco AG, Barroso PF, Melo MF, Schechter M, J Acquir Immune Defic Syndr 2006 43 401 404 10.1097/01.qai.0000243117.21788.90 17031316 (Pubitemid 44737095)
8. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Cote d'Ivoire, 1997-2000. Salamon R, Marimoutou C, Ekra D, Minga A, Nerrienet E, Huet C, Gourvellec G, Bonard D, Coulibaly I, Combe P, Dabis F, Bondurand A, Montagnier L, J Acquir Immune Defic Syndr 2002 29 149 157 11832684 (Pubitemid 34164886)
9. Argentinean National Health Ministry, AIDS and STD Department, 26th Bulletin of HIV-AIDS in Argentina Buenos Aires 2009
10. Describing the acute HIV infection in Argentina: preliminary results of the Grupo Argentino de Seroconversion. 4th International Workshop on HIV Transmission. Socías ME, Reviews in Antiviral Therapy 2009 7 12
11. Baseline characteristics in HIV primary infections in Argentina: multicentric study [THPE0085]. Sued O, Laufer N, Amante L, Remondegui C, Lazaro M, Zala C, Cangelosi D, Castelli J, Cabrini M, Figueroa MI, Duarte A, Socías ME, Rolon M, Crudo F, Garda E, Gun A, Krolewiecki A, Gomez-Carrillo M, Salomán H, Zapatella M, Perez H, Cahn P, XVII International AIDS Conference 3-8 August 2008; Mexico City 19062410
12. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989 38 1 7 2513473
13. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Cooper DA, Gold J, Maclean P, Donovan B, Finlayson R, Barnes TG, Michelmore HM, Brooke P, Penny R, Lancet 1985 1 537 540 2857899 (Pubitemid 15101846)
14. Primary HIV type 1 infection. Kassutto S, Rosenberg ES, Clin Infect Dis 2004 38 1447 1453 10.1086/420745 15156484 (Pubitemid 38668592)
15. -1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992 41 1 19 1480128
16. Comparison of Early CD4 T-Cell Count in HIV-1 Seroconverters in Cote d'Ivoire and France: The ANRS PRIMO-CI and SEROCO Cohorts. Lewden C, Thiebaut R, Boufassa F, Coulibaly A, Malateste K, Seng R, Toni TD, Inwoley A, Rouzioux C, Minga A, Anglaret X, Meyer L, J Acquir Immune Defic Syndr 2009
17. Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003). Sued O, Miro JM, Alquezar A, Claramonte X, Garcia F, Plana M, Arnedo M, de Lazzari E, Gil C, Manzardo C, Blanco JL, Martinez E, Mallolas J, Joseph J, Pumarola T, Gallart T, Gatell JM, Enferm Infecc Microbiol Clin 2006 24 238 244 10.1016/S0213-005X(06)73769-7 16725083 (Pubitemid 43874420)
18. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Goujard C, Bonarek M, Meyer L, Bonnet F, Chaix ML, Deveau C, Sinet M, Galimand J, Delfraissy JF, Venet A, Rouzioux C, Morlat P, Clin Infect Dis 2006 42 709 715 10.1086/500213 16447119 (Pubitemid 43271388)
19. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. World Health Organization, 2010 revision WHO 2010
20. Sociedad Argentina de Infectología, III Argentinean Consensus of Antirretroviral Therapy Buenos Aires 2010
21. Clinical and epidemiologic features of primary HIV infection. Schacker T, Collier AC, Hughes J, Shea T, Corey L, Ann Intern Med 1996 125 257 264 8678387 (Pubitemid 126449269)
22. Identifying People with Acute HIV Infection: Demographic Features, Risk Factors, and Use of Health Care among Individuals with AHI in North Carolina. Hightow-Weidman LB, Golin CE, Green K, Shaw EN, Macdonald PD, Leone PA, AIDS Behav 2009
23. HIV seroconversion complicated by Mycobacterium kansasii infection. Lillie PJ, Barlow GD, Moss PJ, Parsonage MJ, Adams K, Thaker HK, Aids 2007 21 650 652 10.1097/QAD.0b013e32803277e9 17314530
24. Fatal disseminated toxoplasmosis during primary HIV infection. Signorini L, Gulletta M, Coppini D, Donzelli C, Stellini R, Manca N, Carosi G, Matteelli A, Curr HIV Res 2007 5 273 274 10.2174/157016207780077011 17346141 (Pubitemid 46488203)
25. Unusual presentations of primary human immunodeficiency virus infection. Szabo S, James CW, Telford G, AIDS Patient Care STDS 2002 16 251 254 10.1089/10872910260066688 12133260 (Pubitemid 34620333)
26. Multiple organ failure during primary HIV infection. Tattevin P, Camus C, Arvieux C, Ruffault A, Michelet C, Clin Infect Dis 2007 44 28 29 10.1086/510683 17205433
27. Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH, Richardson BA, Mandaliya K, Ndinya-Achola JO, Kreiss JK, Clin Infect Dis 2002 35 77 81 10.1086/340862 12060878 (Pubitemid 34666863)
28. The relation between symptoms, viral load, and viral load set point in primary HIV infection. Kelley CF, Barbour JD, Hecht FM, J Acquir Immune Defic Syndr 2007 45 445 448 10.1097/QAI.0b013e318074ef6e 17514014 (Pubitemid 47057672)
29. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Vanhems P, Lambert J, Cooper DA, Perrin L, Carr A, Hirschel B, Vizzard J, Kinloch-de Loes S, Allard R, Clin Infect Dis 1998 26 323 329 10.1086/516289 9502449 (Pubitemid 28083941)
30. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. Munoz A, Wang MC, Bass S, Taylor JM, Kingsley LA, Chmiel JS, Polk BF, Am J Epidemiol 1989 130 530 539 2669471 (Pubitemid 19214620)
31. Time to reaching CD4 500 for individuals followed-up since HIV seroconversion [MOPEB050]. Lodi S, Porter K, Philips A, 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 19-22 July Cape Town, South Africa 2009 20519026
32. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, Mandaliya K, Ndinya-Achola JO, Overbaugh J, Clin Infect Dis 2006 42 1333 1339 10.1086/503258 16586394
33. Immune control of HIV-1 after early treatment of acute infection. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD, Nature 2000 407 523 526 10.1038/35035103 11029005
34. Viral dynamics of acute HIV-1 infection. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV, J Exp Med 1999 190 841 850 10.1084/jem.190.6.841 10499922 (Pubitemid 29451629)
35. Primary HIV-1 subtype C infection in Ethiopia. Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL, J Acquir Immune Defic Syndr 2002 30 463 470 10.1097/00126334-200208150-00001 12154336
36. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br? Santoro-Lopes G, Harrison LH, Tavares MD, Xexeo A, Dos Santos AC, Schechter M, AIDS Res Hum Retroviruses 2000 16 953 958 10.1089/08892220050058362 10890356 (Pubitemid 30436493)
37. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, Wabwire-Mangen F, Serwadda D, Sewankambo NK, Quinn TC, Wawer M, Gray R, J Infect Dis 2008 197 707 713 10.1086/527416 18266607 (Pubitemid 351364471)
38. Human immunodeficiency virus type 1 subtypes differ in disease progression. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, I ND, Essex ME, S MB, J Infect Dis 1999 179 68 73 10.1086/314557 9841824 (Pubitemid 29028340)
39. Baseline HIV type 1 coreceptor tropism predicts disease progression. Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM, Clin Infect Dis 2007 45 643 649 10.1086/520650 17683002 (Pubitemid 47328648)
40. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC, N Engl J Med 2001 344 720 725 10.1056/NEJM200103083441003 11236775 (Pubitemid 32204989)
41. Gender difference in HIV-1 RNA viral loads. Donnelly CA, Bartley LM, Ghani AC, Le Fevre AM, Kwong GP, Cowling BJ, van Sighem AI, de Wolf F, Rode RA, Anderson RM, HIV Med 2005 6 170 178 10.1111/j.1468-1293.2005.00285.x 15876283 (Pubitemid 40740333)
42. Association of race and gender with HIV-1 RNA levels and immunologic progression. Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, Munoz A, Greenblatt RM, J Acquir Immune Defic Syndr 2000 24 218 226 10969345
43. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR Jr, Mann D, Apple R, Phair JP, Detels R, O'Brien S, Enger C, Johnson P, Kaslow RA, Aids 1998 12 2107 2113 10.1097/00002030-199816000-00005 9833851 (Pubitemid 28495264)
44. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, Rockstroh JK, Goulder PJ, Walker BD, Aids 2003 17 2581 2591 10.1097/00002030-200312050-00005 14685052 (Pubitemid 38402336)
45. Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. Crum-Cianflone N, Eberly L, Zhang Y, Ganesan A, Weintrob A, Marconi V, Barthel RV, Fraser S, Agan BK, Wegner S, Clin Infect Dis 2009 48 1285 1292 10.1086/597777 19309306
46. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. Dorrucci M, Rezza G, Porter K, Phillips A, J Infect Dis 2007 195 525 534 10.1086/510911 17230412 (Pubitemid 46214395)
47. Increasing clinical virulence in two decades of the Italian HIV epidemic. Muller V, Maggiolo F, Suter F, Ladisa N, De Luca A, Antinori A, Sighinolfi L, Quiros-Roldan E, Carosi G, Torti C, PLoS Pathog 2009 5 1000454 10.1371/journal.ppat.1000454 19478880
48. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. Dalmau J, Puertas MC, Azuara M, Marino A, Frahm N, Mothe B, Izquierdo-Useros N, Buzon MJ, Paredes R, Matas L, Allen TM, Brander C, Rodrigo C, Clotet B, Martinez-Picado J, Clin Infect Dis 2009 48 229 238 10.1086/595704 19093810
49. HLA and AIDS: a cautionary tale. O'Brien SJ, Gao X, Carrington M, Trends Mol Med 2001 7 379 381 10.1016/S1471-4914(01)02131-1 11530315 (Pubitemid 32825514)
50. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R, AIDS Res Hum Retroviruses 2009 25 183 191 10.1089/aid.2008.0140 19239357
51. HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. Kared H, Lelievre JD, Donkova-Petrini V, Aouba A, Melica G, Balbo M, Weiss L, Levy Y, Aids 2008 22 2451 2460 10.1097/QAD. 0b013e328319edc0 19005268
52. HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. Dilernia DA, Gomez AM, Lourtau L, Marone R, Losso MH, Salomon H, Gomez-Carrillo M, AIDS Res Hum Retroviruses 2007 23 1201 1207 10.1089/aid.2007.0068 17961105 (Pubitemid 350017602)
53. Evidence of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina. Masciotra S, Livellara B, Belloso W, Clara L, Tanuri A, Ramos AC, Baggs J, Lal R, Pieniazek D, AIDS Res Hum Retroviruses 2000 16 1007 1014 10.1089/08892220050058425 10890362 (Pubitemid 30436499)
54. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. Thomson MM, Villahermosa ML, Vazquez-de-Parga E, Cuevas MT, Delgado E, Manjon N, Medrano L, Perez-Alvarez L, Contreras G, Carrillo MG, Salomon H, Najera R, Aids 2000 14 897 899 10.1097/00002030-200005050-00020 10839601 (Pubitemid 30303471)
55. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russell KL, Carr JK, J Acquir Immune Defic Syndr 2002 29 422 426 11917249 (Pubitemid 34288898)
56. Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodriguez C, Chiocconi E, Lazaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltran M, Benetucci JA, J Acquir Immune Defic Syndr 2006 42 506 510 10.1097/01.qai.0000222285.44460. e2 16773027 (Pubitemid 44050902)
57. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Pincus JM, Crosby SS, Losina E, King ER, LaBelle C, Freedberg KA, Clin Infect Dis 2003 37 1699 1704 10.1086/379772 14689354 (Pubitemid 37549959)
58. Acute HIV infection among patients tested for mononucleosis. Rosenberg ES, Caliendo AM, Walker BD, N Engl J Med 1999 340 969 10094652 (Pubitemid 29141066)
59. Effect of early versus deferred antiretroviral therapy for HIV on survival. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, N Engl J Med 2009 360 1815 1826 10.1056/NEJMoa0807252 19339714
60. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miro JM, Justice AC, Ledergerber B, Fatkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR, Lancet 2009 373 1352 1363 19361855